. A high incidence of glucose intolerance has been found among patients with Friedreich's ataxia (Shapcott et al, 1976) and is thought to be due, among other factors to the absence of exercise and immobilization of these patients. Furthermore, preliminary data has indicated that there may be a familial component (Draper et al, 1979; Andermann et al, 1976) .
In order to establish whether the above factors are involved, we assessed glycemia and insulin release to orally ingested glucose in families of patients with Friedreich's ataxia (parents and siblings) with or without the neuromuscular deficits.
PATIENTS
Our study group consisted of 16 families. Among them at least one member of each family had Friedreich's ataxia defined by well established criteria . Practically all patients had varying degrees of ataxia ranging from impeded mobility to movement with difficulty and assistance. None of the siblings or parents had any neuromuscular disorder and none of the families was on any medications affecting pancreatic function or other endocrine glands. The parents differed from the offsprings in terms of body weight: 11 of 15 were overweight whereas the siblings were around ideal weight and the patients were largely underweight (9 out of 15).
METHODS
All subjects were instructed to eat an adequate carbohydrate diet ( > 250 grams daily for three days) and report to the nursing station after overnight fasting. An indwelling catheter was placed in an antecubital vein and blood was collected at 30 minute intervals for three hours for the determination of blood glucose (G), insulin (I), growth hormone (GH) and prolactin (PRL). Blood glucose was determined by auto-analyser and insulin by standard radioimmunoassay technique (Keen et al, 1979) .
A glucose curve was interpreted using guidelines established by Danowski et al (1975) and the National Institute of Health (Keen et al, 1979) (Table 1 ). The area under the curve (AUC) for glucose (AUC-G) or insulin (AUC-I) was calculated by using the formula:
(0 min. value)+2 (30 min)+3 (60 min)+2 (120 min) 4
The elevation of insulin release per glycemia achieved following glucose ingested was evaluated by regression analysis. The student's T test (two tailed) was applied to compare the AUC-G and AUC-I among groups. M e a s u r e m e n t s of glycosylated hemoglobin (AIC) levels were made with the use of a kit.
RESULTS

A. Family Histories
In at least 50% of the various groups tested there was a positive family history for diabetes (Tables 2, 3, 4) . Of interest was the fact that among homozygotes (F.A. patients) and obligatory heterozygotes (parents) a 
B. O.G.T.T.
The percent of subjects (homozygotes : patients; obligatory heterozygotes : parents; and potential carriers : siblings) presenting with overt diabetes or IGT differed according to the criteria employed (Tables 2, 3, 4). Employing the Danowski criteria, abnormalities in glucose tolerance were identified with higher frequency (more than 50% in all groups). A significant (p<0.001) difference was found when comparing the area under the curve for glucose (AUC-G) between those with normal GTT and those identified as having IGT (mean ± S.D. values were 250.9±28 and 297.8±24.7 respectively).
No difference was found when comparing the insulin output (AUC-I) among groups. Furthermore, we were unable to establish a significant correlation between the AUC-G and the AUC-I analysed by linear regression when the insulin release was analysed qualitatively among those subjects with IGT, over 75% of whom had a delayed insulin peak or a second spike.
C. Hemoglobin A\C
Abnormally elevated values were found in 3 out of 4 diabetic family members. Among the rest, mildly elevated values were seen in some members with IGT although this was not consistent. One "normal" (by NIH criteria) parent had as high a value as that seen in a diabetic patient (see Table 3 ).
DISCUSSION
Previous investigators had found a high incidence of diabetes or abnormal glucose tolerance among patients with Friedreich's ataxia (Shapcott et al, 1976; Draper et al, 1979; Andermann et al, 1976) . Our data is in agreement with these reports. In addition we now report that an impaired glucose tolerance is also present among obligatory heterozygotes and potential carriers. This finding could be taken to suggest a genetic defect in carbohydrate homeostasis in Friedreich's ataxia. The strong association, however, between family history and IGT may Key -see Table II be taken to suggest that the IGT is due to a hereditary factor unrelated to the Friedreich's ataxia genetic background. Of course, if there were a method i.e. HLA typing, chromosome banding or other marker, whereby one could show a positive correlation with the IGT then one could infer that there is a common link between Friedreich's ataxia genes and expression of IGT. Although our data cannot evaluate this possibility they offer other pathophysiologic insights. The findings of IGT in parents and siblings (in addition to patients) who suffer no neuromuscular disease suggests that the role of muscular immobility in glucose disposal, if anything, is restricted. Furthermore, the absence of insulinopenia in all groups with IGT indicates that at the early stages of glucose intolerance there is no quantitative defect in insulin release. Our finding that over 75% have a delayed insulin peak or a second late insulin rise following orally provoked hyperglycemia suggest a qualitative disturbance in insulin release mechanism as described in early diabetes. On the other hand, the presence of hyperglycemia despite a normal (quantitatively) insulin output suggests that there is a defect in the cellular components associated with glucose entry. Since this was observed both in the overweight parents and normal underweight siblings and patients, body weight does not seem to be of great importance; one has rather to propose a disorder situated after the binding of insulin to its receptor (which seems to be intact at least for erythrocytes) (Shapcott et al, 1976) .
Thus, it appears that the IGT can be explained on a dual basis: abnormal insulin release and insulin action. Whatever the cause we suggest that all subjects with IGT be properly treated in order to avoid possible long term complications.
